Breaking News
Top News
-
Jim Cramer on Infleqtion: “Take a Little Profit and You Can Buy It Back Lower”
-
Jim Cramer on Netskope: “It’s Not My Cup of Tea, But It Looks Like It’s Bottoming”
-
Jim Cramer on Flex Ltd.: “I Just Can’t Recommend It Here, It’s Too High”
-
Jim Cramer Says “I Got to Reopen the File on Biogen”
-
Jim Cramer Called Johnson & Johnson “The Best Drug Stock, or at Least the Second-Best”
-
Absolute Advisers Adds BlackRock’s HYT ETF to Its Alternative Investment Approach
-
Here Are Thursday’s Top Wall Street Analyst Research Calls: Boston Scientific, Datadog, Deckers Outdoor, McDonald’s, Murphy USA, On Semiconductor, Palantir Technologies, Texas Instruments, and More
-
Here’s Why Nvidia and Broadcom Are Still Leading the Pack for AI Investing
-
Southwest Airlines Q1 2026 earnings: profit, fuel cost warning
-
2 Growth Stocks Down 6% (or More) to Buy Right Now
-
Tesla’s $25 billion spending plan tests investor faith in unproven AI bets
-
Keurig Dr Pepper Q1 2026 earnings beat estimates
-
Honeywell stock drops 6% as profit forecast misses on Iran war impact
-
Wendel completes acquisition of 56% stake in Committed Advisors
-
Dangote Vows to Build Nigeria-Style Oil Refinery in East Africa
-
Keurig Dr Pepper Rises as Cold Drinks Drives Earnings Beat
-
Air France-KLM, Lufthansa Bids Advance in Race for TAP Stake
-
Oil Climbs with Iran Talks in Limbo; Tesla Boosts Spending Plan to $25B | Bloomberg Brief 4/23/2026
-
Dow Rises as Higher Prices Help Revenue Guidance Beat Estimates
-
Iran War: Stocks Fall as Oil Climbs With Talks in Limbo | The Opening Trade 4/23/2026
2026-02-05

























